Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer
- PMID: 1735085
- DOI: 10.1002/1097-0142(19920215)69:4<941::aid-cncr2820690418>3.0.co;2-h
Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer
Abstract
The relationship was analyzed between drug resistance and MDR1 (with MDR signifying multiple drug resistance) and glutathione S transferase-pi (GST-pi) gene expression in four stomach and four colon cancer cell lines. Northern blot analysis by pmdr1 probe showed that stomach cancer cell lines had no detectable level of MDR1 mRNA expression. By contrast, some levels of MDR1 mRNA expression were found in two colon cancer cell lines, indicating doxorubicin resistance. To examine the MDR1 mRNA in each cell level, in situ hybridization was used. It was found that all colon cell lines and two stomach cell lines had more silver grains per cell than KB cells (a human KB kidney epidermoid carcinoma cell line). However, the number of silver grains in each cell was heterogeneous in the colon and stomach cell lines. Low-level MDR1 mRNA expression could be detected even in cell lines without MDR1 mRNA expression by northern blot hybridization. These results suggest the possibility that all gastrointestinal cell lines can acquire multiple drug resistance. In addition, all examined gastrointestinal cell lines had high GST-pi mRNA expression. This GST-pi gene expression shows cisplatin resistance in the examined cell lines. Heterogeneity of GST-pi mRNA expression also was shown at the cellular level.
Similar articles
-
Establishment of drug resistance in human gastric and colon carcinoma xenograft lines.Jpn J Cancer Res. 1991 May;82(5):593-8. doi: 10.1111/j.1349-7006.1991.tb01891.x. Jpn J Cancer Res. 1991. PMID: 1905705 Free PMC article.
-
Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.Mol Pharmacol. 1990 Jun;37(6):801-9. Mol Pharmacol. 1990. PMID: 1972772
-
Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity.Br J Cancer. 1990 May;61(5):712-6. doi: 10.1038/bjc.1990.160. Br J Cancer. 1990. PMID: 1970934 Free PMC article.
-
[Glutathione S transferases-pi].Gan To Kagaku Ryoho. 1994 Jun;21(7):945-51. Gan To Kagaku Ryoho. 1994. PMID: 8002632 Review. Japanese.
-
Is the glutathione S-conjugate carrier an mdr1 gene product?Trends Biochem Sci. 1990 Jun;15(6):219-20. doi: 10.1016/0968-0004(90)90032-7. Trends Biochem Sci. 1990. PMID: 2200165 Review. No abstract available.
Cited by
-
Expression of glutathione-S-transferases alpha and pi in gastric cancer: a correlation with cisplatin resistance.Cancer Chemother Pharmacol. 1994;34(3):203-8. doi: 10.1007/BF00685078. Cancer Chemother Pharmacol. 1994. PMID: 8004752
-
Molecular chess? Hallmarks of anti-cancer drug resistance.BMC Cancer. 2017 Jan 5;17(1):10. doi: 10.1186/s12885-016-2999-1. BMC Cancer. 2017. PMID: 28056859 Free PMC article. Review.
-
Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes.Biochem J. 2005 Mar 15;386(Pt 3):525-33. doi: 10.1042/BJ20041419. Biochem J. 2005. PMID: 15471539 Free PMC article.
-
Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.Int J Mol Sci. 2022 Feb 6;23(3):1853. doi: 10.3390/ijms23031853. Int J Mol Sci. 2022. PMID: 35163777 Free PMC article. Review.
-
NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells.Funct Integr Genomics. 2023 Mar 30;23(2):111. doi: 10.1007/s10142-023-01041-z. Funct Integr Genomics. 2023. PMID: 36995552
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous